Both scientific groups will cooperate on a traditional knowledge-based plant research platform to discover local plant species which have the potential to be developed as anti-inflammatory drug candidates for pharmaceutical or nutraceutical application.

The NUS Drug Development and Optimization Program (DDOP) is led by Associate Professor W.S. Fred Wong, and the program’s primary objective is empowering researchers to generate a highly therapeutic pipeline of new molecular entities. The team comprises of members who specialise in the drug development continuum, from target identification to validation with disease models.